Biological topicals in ocular surface disorders
Topical biological agents represent a significant advancement in the treatment of ocular surface diseases, offering a regenerative and cashel tail bag therapeutic approach beyond conventional therapies.These agents are derived from serum (autologous or allogeneic), platelets, amniotic membrane, and pooled intravenous immunoglobulin.Their efficacy s